Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients.

Erlotinib treatment induces cytochrome P450 3A activity in non-small cell lung cancer patients. — المؤلف: Svedberg, Anna — British journal of clinical pharmacology 20200824

المؤلف
Svedberg, Anna
النشر
British journal of clinical pharmacology 20200824
الوصف
1704-1709 p.
الموضوعات
Aged؛ Aged, 80 and over؛ Carcinoma, Non-Small-Cell Lung؛ Cytochrome P-450 CYP3A؛ Drug Interactions؛ Drug Monitoring؛ Erlotinib Hydrochloride؛ Female